SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

sugammadex-teva sugammadex (as sodium) 200 mg/2 ml solution for injection vial

teva pharma australia pty ltd - sugammadex sodium, quantity: 217.6 mg (equivalent: sugammadex, qty 200 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

Dextrose 5% Solution For Infusion Kenija - angļu - Pharmacy and Poisons Board

dextrose 5% solution for infusion

topstone pharma limited godown b10, kenafric business park, baba dogo - dextrose - solution for infusion - dextrose 5g - glucose

Dextrose 5% Solution For Infusion Kenija - angļu - Pharmacy and Poisons Board

dextrose 5% solution for infusion

medina remedies limited old mombasa road - dextrose 5mg bp - solution for infusion - dextrose 5mg bp - glucose

RINGERS- sodium chloride, calcium chloride, and potassium chloride injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

ringers- sodium chloride, calcium chloride, and potassium chloride injection, solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (chloride ion - unii:q32zn48698, potassium cation - unii:295o53k152) - sodium chloride 0.86 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. the use of ringer’s injection usp is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, or chloride could be clinically detrimental.

DEXTROSE injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose injection, solution

physicians total care, inc. - dextrose monohydrate (unii: lx22yl083g) (dextrose - unii:iy9xdz35w2) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

DEXTROSE injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose injection, solution

hf acquisition co llc, dba healthfirst - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

DEXTROSE- dextrose monohydrate injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection, solution

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. check for leaks by squeezing container firmly. if leaks are found, discard unit as sterility may be impaired. if supplemental medication is desired, follow directions below before preparing for administration. to add medication (use aseptic technique) preparation for administration (use aseptic technique) note: see appropriate i.v. administration set instructions for use. warning: do not use flexible container in series connections.

DEXTROSE- dextrose monohydrate injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection, solution

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

DEXTROSE AND SODIUM CHLORIDE- dextrose monohydrate and sodium chloride injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose and sodium chloride- dextrose monohydrate and sodium chloride injection, solution

icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. to add medication - prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. - mix container contents thoroughly. preparation for administration (use aseptic technique) - close flow control clamp of administration set. - remove cover from outlet port at bottom of container. - insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. note: when using a vented administration set, replace bacterial retentive air filter with piercing pin cover. insert piercing pin with twisting motion until shoulder of air filter housing rests against the outlet port flange. - suspend container from hanger. - squeeze and release drip chamber to establish proper fluid level in chamber. - attach venipuncture device to set. - open clamp to expel air from set and venipuncture device. close clamp. - perform venipuncture. - regulate rate of administration with flow control clamp. warning: do not use flexible container in series connections.